168 related articles for article (PubMed ID: 4051447)
1. Hepatic acetylator phenotype in bladder cancer patients.
Ladero JM; Kwok CK; Jara C; Fernandez L; Silmi AM; Tapia D; Uson AC
Ann Clin Res; 1985; 17(3):96-9. PubMed ID: 4051447
[TBL] [Abstract][Full Text] [Related]
2. Genetically determined sparteine oxidation and sulfadimidine acetylation polymorphism in patients with non-occupational urinary bladder cancer.
Orzechowska-Juzwenko K; Niewiński P; Pawlik J; Milejski P; Dembowski J; Swiebodzki L; Lorenz J
Mater Med Pol; 1994; 26(4):145-8. PubMed ID: 7666680
[TBL] [Abstract][Full Text] [Related]
3. Polymorphic N-acetylation of sulfamethazine and benzidine by human liver: implication for cancer risk?
Peters JH; Gordon GR; Lin E; Green CE; Tyson CA
Anticancer Res; 1990; 10(1):225-9. PubMed ID: 2334132
[TBL] [Abstract][Full Text] [Related]
4. Acetylation phenotypes in patients with bladder carcinoma.
Bicho MP; Breitenfeld L; Carvalho AA; Manso CF
Ann Genet; 1988; 31(3):167-71. PubMed ID: 3265609
[TBL] [Abstract][Full Text] [Related]
5. [Acetylation phenotype in patients with cancer of the bladder. Preliminary report].
Skretowicz J; Polakowski P; Jeromin L; Zasada M; Szymańska J; Krajewska B
Med Pr; 1988; 39(4):241-5. PubMed ID: 3237058
[TBL] [Abstract][Full Text] [Related]
6. Acetylation phenotype in colorectal carcinoma.
Ilett KF; David BM; Detchon P; Castleden WM; Kwa R
Cancer Res; 1987 Mar; 47(5):1466-9. PubMed ID: 3815349
[TBL] [Abstract][Full Text] [Related]
7. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction.
Marcus PM; Hayes RB; Vineis P; Garcia-Closas M; Caporaso NE; Autrup H; Branch RA; Brockmöller J; Ishizaki T; Karakaya AE; Ladero JM; Mommsen S; Okkels H; Romkes M; Roots I; Rothman N
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):461-7. PubMed ID: 10815690
[TBL] [Abstract][Full Text] [Related]
8. The association of the slow acetylator phenotype with bladder cancer.
Evans DA; Eze LC; Whibley EJ
J Med Genet; 1983 Oct; 20(5):330-3. PubMed ID: 6644762
[TBL] [Abstract][Full Text] [Related]
9. [Determination of the N-acetyltransferase phenotype in urothelial cancer patients and healthy controls].
Sone M
Hinyokika Kiyo; 1986 Aug; 32(8):1085-92. PubMed ID: 3788733
[TBL] [Abstract][Full Text] [Related]
10. Hepatic acetylator phenotype in diabetes mellitus.
Ladero JM; Arrojo A; de Salamanca RE; Gomez M; Cano F; Alfonso M
Ann Clin Res; 1982 Aug; 14(4):187-9. PubMed ID: 7168549
[TBL] [Abstract][Full Text] [Related]
11. Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe.
William BM; Abdel-tawab AM; Hassan EA; Mohamed OF
Pol J Pharmacol; 2004; 56(4):445-9. PubMed ID: 15520499
[TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiology of bladder cancer.
Vineis P; Martone T
Ann Ist Super Sanita; 1996; 32(1):21-7. PubMed ID: 8967722
[TBL] [Abstract][Full Text] [Related]
13. Correlation between N-acetyltransferase activities in uroepithelia and in vivo acetylator phenotype.
Pink JC; Messing EM; Reznikoff CA; Bryan GT; Swaminathan S
Drug Metab Dispos; 1992; 20(4):559-65. PubMed ID: 1356735
[TBL] [Abstract][Full Text] [Related]
14. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
[TBL] [Abstract][Full Text] [Related]
15. [The acetylator phenotype in patients with urinary bladder cancer].
Wich H; Franke G; Grimm U; Siegmund W
Z Urol Nephrol; 1989 Nov; 82(11):597-9. PubMed ID: 2618184
[TBL] [Abstract][Full Text] [Related]
16. Acetylation phenotype, carcinogen-hemoglobin adducts, and cigarette smoking.
Vineis P; Caporaso N; Tannenbaum SR; Skipper PL; Glogowski J; Bartsch H; Coda M; Talaska G; Kadlubar F
Cancer Res; 1990 May; 50(10):3002-4. PubMed ID: 2334904
[TBL] [Abstract][Full Text] [Related]
17. Acetylator polymorphism in human colorectal carcinoma.
Ladero JM; González JF; Benítez J; Vargas E; Fernández MJ; Baki W; Diaz-Rubio M
Cancer Res; 1991 Apr; 51(8):2098-100. PubMed ID: 2009528
[TBL] [Abstract][Full Text] [Related]
18. Acetylator phenotype in human bladder cancer.
Miller ME; Cosgriff JM
J Urol; 1983 Jul; 130(1):65-6. PubMed ID: 6864917
[TBL] [Abstract][Full Text] [Related]
19. Role of N-acetyltransferase phenotype in human susceptibility to bladder carcinogenic arylamines.
Wolf H; Lower GM; Bryan GT
Scand J Urol Nephrol; 1980; 14(2):161-5. PubMed ID: 7209420
[TBL] [Abstract][Full Text] [Related]
20. [Distribution of acetylator phenotypes in the normal Moscow city population and in chronic alcoholism].
Lil'in ET; Korsunskaia MP; Meksin VA; Drozdov ES; Nazarov VV
Genetika; 1984 Sep; 20(9):1557-9. PubMed ID: 6542045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
